4181 - 4190 of 9148 Results
Title
Year
-
OPENTitle: Pharmacologically distinct pramipexole-mediated akinesia vs. risk-taking in a rat model of Parkinson's diseaseJournal Name: Progress in Neuro-Psychopharmacology and Biological PsychiatryPublisher: Elsevier BVVol: 70Issue #:Start Page: 77End Page: 84Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.pnpbp.2016.05.004Best OA location URL: http://doi.org/10.1016/j.pnpbp.2016.05.004Citation Count: 27
- Advanced Age, Cardiovascular Risk Burden, and Timed Up and Go Test Performance in Parkinson Disease2014OPENTitle: Advanced Age, Cardiovascular Risk Burden, and Timed Up and Go Test Performance in Parkinson DiseaseJournal Name: The Journals of Gerontology Series A: Biological Sciences and Medical SciencesPublisher: Oxford University Press (OUP)Vol: 69Issue #: 12Start Page: 1569End Page: 1575Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/gerona/glu070Best OA location URL: https://academic.oup.com/biomedgerontology/article-pdf/69/12/1569/9705604/glu070.pdfCitation Count: 15
- Enantiomeric Propanolamines as selectiveN-Methyl-d-aspartate 2B Receptor Antagonists2008OPENTitle: Enantiomeric Propanolamines as selectiveN-Methyl-d-aspartate 2B Receptor AntagonistsJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 51Issue #: 18Start Page: 5506End Page: 5521Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/jm8002153Citation Count: 25
- Quinazolin-4-one Derivatives: A Novel Class of Noncompetitive NR2C/D Subunit-SelectiveN-Methyl-d-aspartate Receptor Antagonists2010OPENTitle: Quinazolin-4-one Derivatives: A Novel Class of Noncompetitive NR2C/D Subunit-SelectiveN-Methyl-d-aspartate Receptor AntagonistsJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 53Issue #: 15Start Page: 5476End Page: 5490Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/jm100027pCitation Count: 85
- Discovery, Synthesis, and Structure–Activity Relationship Development of a Series of N-4-(2,5-Dioxopyrrolidin-1-yl)phenylpicolinamides (VU0400195, ML182): Characterization of a Novel Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 4 (mGlu4) with Oral Efficacy in an Antiparkinsonian Animal Model2011OPENTitle: Discovery, Synthesis, and Structure–Activity Relationship Development of a Series of N-4-(2,5-Dioxopyrrolidin-1-yl)phenylpicolinamides (VU0400195, ML182): Characterization of a Novel Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 4 (mGlu4) with Oral Efficacy in an Antiparkinsonian Animal ModelJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 54Issue #: 21Start Page: 7639End Page: 7647Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/jm200956qCitation Count: 61
-
OPENTitle: Apathy and Depression: Separate Factors in Parkinson's DiseaseJournal Name: Journal of the International Neuropsychological SocietyPublisher: Cambridge University Press (CUP)Vol: 17Issue #: 6Start Page: 1058End Page: 1066Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1017/s1355617711001068Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3302577Citation Count: 140
- Discovery, Synthesis, and Structure−Activity Relationship Development of a Series of N-(4-Acetamido)phenylpicolinamides as Positive Allosteric Modulators of Metabotropic Glutamate Receptor 4 (mGlu4) with CNS Exposure in Rats2011OPENTitle: Discovery, Synthesis, and Structure−Activity Relationship Development of a Series of N-(4-Acetamido)phenylpicolinamides as Positive Allosteric Modulators of Metabotropic Glutamate Receptor 4 (mGlu4) with CNS Exposure in RatsJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 54Issue #: 4Start Page: 1106End Page: 1110Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/jm101271sCitation Count: 48
-
OPENTitle: Nicotine up-regulates α4β2 nicotinic receptors and ER exit sites via stoichiometry-dependent chaperoningJournal Name: Journal of General PhysiologyPublisher: Rockefeller University PressVol: 137Issue #: 1Start Page: 59End Page: 79Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1085/jgp.201010532Best OA location URL: https://rupress.org/jgp/article-pdf/137/1/59/1187438/jgp_201010532.pdfCitation Count: 167
- TDP-43 pathology and neuronal loss in amyotrophic lateral sclerosis spinal cord2014RESTRICTEDTitle: TDP-43 pathology and neuronal loss in amyotrophic lateral sclerosis spinal cordJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 128Issue #: 3Start Page: 423End Page: 437Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00401-014-1299-6Citation Count: 288
- Higher serum cholesterol and decreased Parkinson's disease risk: A statin‐free cohort study2018RESTRICTEDTitle: Higher serum cholesterol and decreased Parkinson's disease risk: A statin‐free cohort studyJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 8Start Page: 1298End Page: 1305Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27413Citation Count: 131